Riskpilot← Back to searchSign inGet full accessJOR Aktiebolag
ABActiveOrg 5562785724Rubanksgatan 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19867 employees
Revenue 2024
SEK 27,9M
+8% vs 2023
EBITDA margin
11.8%
+86% vs 2023
Equity ratio
42.5%
Financial strength
Net profit 2024
SEK 2,5M
+105% vs 2023
| Revenue | SEK 27,9M | +8% |
| EBITDA | SEK 3,3M | +86% |
| Net profit | SEK 2,5M | +105% |
| Total assets | SEK 11,4M | +62% |
| Equity | SEK 4,9M | +106% |
| Employees | 7 | — |
Legal name
JOR Aktiebolag
Org number
5562785724
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11 juli 1986
Share capital
SEK 150 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall försälja medicintekniska produkter och elektroniska mätinstrument, ävensom idka därmed förenlig verksamhet.
Address
Rubanksgatan 4
Phone
+4618342820
Email
cecilia@jor.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 17 848 | 19 810 | 31 962 | 25 883 | 27 855 |
| Staff expenses | — | — | — | −3 287 | −3 965 |
| EBITDA | −961 | 180 | 1 384 | 1 770 | 3 285 |
| Depreciation & amort. | −6 | −19 | −14 | −30 | −30 |
| EBIT | −967 | 161 | 1 370 | 1 740 | 3 255 |
| Net financials | −42 | −80 | −73 | −176 | −97 |
| Profit before tax | −338 | 81 | 1 034 | 1 564 | 3 159 |
| Tax | −0 | −0 | −163 | −339 | −653 |
| Net profit | −338 | 81 | 871 | 1 225 | 2 505 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 556 | 7 160 | 15 903 | 7 075 | 11 441 |
| Equity | 180 | 261 | 1 132 | 2 357 | 4 862 |
| Long-term debt | 0 | 755 | 548 | 1 770 | 0 |
| Short-term debt | 4 376 | 6 144 | 13 958 | 2 684 | 6 315 |
| Total debt | 4 376 | 6 899 | 14 506 | 4 454 | 6 315 |
EBITDA margin
11.8%
This company
15.8%
Market median
-25% vs market
20202024
Equity ratio
42.5%
This company
38.2%
Market median
+11% vs market
20202024
Return on equity
51.5%
This company
18.4%
Market median
+180% vs market
20202024
Net profit margin
9.0%
This company
8.1%
Market median
+11% vs market
20202024
Asset turnover
2.43×
This company
1.12×
Market median
+117% vs market
20202024
Debt / equity
1.35×
This company
0.62×
Market median
-118% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Audit | 2022 | |
MM Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Chairman | 2025 | |
| Former (1) | ||
| Chairman | 2023 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2026 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Moeng Holding AB
JOR Aktiebolag Board members of JOR Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Maria Andersson Dverstorp | Audit | 0 companies |
| Modde Mohammad Wahab | Chief Executive Officer | 0 companies |
| Cecilia Magdalena Palm | Board of Directors | 0 companies |
| Anders Stefan Erik Palm | Chairman | 0 companies |
| Martin Daniel Engström | Chairman | 0 companies |